# US 2014/0193452 A1 · Novel agents for the prevention of leishmaniasis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0193452 A1
- Document ID: US20140193452A1
- Status: Published application
- Kind: A1
- Application number: 14/070,685
- Filed: 2013-11-04
- Published: 2014-07-10
- Earliest claimed: 2003-11-19
- Inventors: JEAN-LOUP LEMESRE; MIREILLE CAVALEYRA; DENIS SERENO; PHILIPPE HOLZMULLER
- Web page: https://patentgrep.com/patent/US20140193452A1

## CPC

- A61K 39/008: Leishmania antigens
- C07K 14/44: from protozoa
- C07K 14/473: {alpha-Glycoproteins}
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The invention relates to nucleic acid constructions, characterized in that they comprise nucleic acids which are isolated in the sense position and which are capable of coding for an immunogenic protein of promastigotes or amastigotes of Leishmania, said nucleic acids responding to one of the sequences SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5 et SEQ ID NO:11 and coding for a protein respectively exhibiting a sequence SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10 et SEQ ID NO:12. The invention can be used for over-expression of the genes of Leishmania coding for an excretion/secretion antigen.

## Claims

### Claim 1

An isolated immunogenic glycoprotein comprising SEQ ID NO:7, said glycoprotein being a Leishmaniasis surface antigen and an excreted/secreted antigen with an apparent molecular weight of 42.5 kDa.

### Claim 2

An isolated immunogenic glycoprotein, the protein being encoded by a nucleic acid sequence comprising SEQ ID NO:2, said glycoprotein being a Leishmaniasis surface antigen and an excreted/secreted antigen with an apparent molecular weight of 42.5 kDa.

### Claim 3 (depends on 1)

A method of immunization, said method comprising administration of the glycoprotein of claim 1 to an animal such that a specific immune response is elicited.

### Claim 4 (depends on 2)

A method of immunization, said method comprising administration of the glycoprotein of claim 2 to an animal such that a specific immune response is elicited.

### Claim 5

An isolated peptide encoded by a nucleic acid sequence comprising SEQ ID NO:2 or comprising SEQ ID NO:7.

### Claim 6 (depends on 1)

An isolated recombinant form of the immunogenic glycoprotein of claim 1.

### Claim 7 (depends on 2)

An isolated recombinant form of the immunogenic glycoprotein of claim 2.

### Claim 8 (depends on 5)

An isolated recombinant form of the peptide of claim 5.
